These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 6411440

  • 1. [Determination of the optimal L-thyroxine dosage for treating nontoxic goiter].
    Biersack HJ, Albrecht W, Oehr P, Rasche A, Winkler C.
    Dtsch Med Wochenschr; 1983 Aug 26; 108(34):1269-73. PubMed ID: 6411440
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation of the optimal thyroxine dose with the TRH test for replacement and suppression therapy].
    Erne P, Staub JJ, Althaus B, Fleig Y, Girard J.
    Schweiz Med Wochenschr; 1983 Dec 17; 113(50):1922-3. PubMed ID: 6420884
    [Abstract] [Full Text] [Related]

  • 3. [Standardisation of TRH test for the exact determination of thyroxine treatment (author's transl)].
    Hesch RD, LeBlanc S, von zur Mühlen A.
    Dtsch Med Wochenschr; 1981 Jan 30; 106(5):146-9. PubMed ID: 6781851
    [Abstract] [Full Text] [Related]

  • 4. A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre.
    De Rosa G, Testa A, Maussier ML, Callà C, Astazi P, Albanese C.
    Horm Metab Res; 1995 Nov 30; 27(11):503-7. PubMed ID: 8770627
    [Abstract] [Full Text] [Related]

  • 5. Nontoxic goitre. II. A study of the pituitary-thyroid axis in 14 recurrent cases.
    Geerdsen JP, Hee P.
    Acta Chir Scand; 1982 Nov 30; 148(3):225-7. PubMed ID: 7136422
    [Abstract] [Full Text] [Related]

  • 6. [Optimization of levothyroxine treatment. Dosage dependence on the existing parenchymal mass, age, body weight and fasting intake].
    Wenzel KW.
    Dtsch Med Wochenschr; 1986 Sep 05; 111(36):1356-62. PubMed ID: 3743448
    [Abstract] [Full Text] [Related]

  • 7. [Thyroxine in the treatment of euthyroid goiter and the prevention of goiter recurrence].
    Goebel R, Leb G, Pohl P, Haralambus I, Warnkross H.
    Acta Med Austriaca; 1976 Sep 05; 3(3):78-80. PubMed ID: 826506
    [Abstract] [Full Text] [Related]

  • 8. The thyroidal T4/T3 ratio and its regulation in non-toxic goitre.
    Reinwein D, Durrer HA, Wiermann H, Löhnert J, von zur Mühlen A.
    Horm Metab Res; 1976 Sep 05; 8(5):394-9. PubMed ID: 824192
    [Abstract] [Full Text] [Related]

  • 9. [Suppressive treatment of normothyroid female goitre patients with reference to patient compliance (author's transl)].
    Kipnowski J, Klingmüller D.
    Dtsch Med Wochenschr; 1982 Mar 19; 107(11):406-10. PubMed ID: 6800754
    [Abstract] [Full Text] [Related]

  • 10. [Thyroxine vs iodine and thyroxine. Comparison of the TSH suppression test].
    Kahaly G, Mihaljevic V, Beyer J, Krause U.
    Schweiz Med Wochenschr; 1989 Jan 14; 119(2):59-64. PubMed ID: 2492674
    [Abstract] [Full Text] [Related]

  • 11. Spontaneous pituitary-thyroid function after surgical treatment of nontoxic goitre. A controlled long-term study.
    Aagaard J, Blichert-Toft M, Axelsson CK, Christiansen C.
    Acta Chir Scand; 1984 Jan 14; 150(2):123-7. PubMed ID: 6426224
    [Abstract] [Full Text] [Related]

  • 12. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G, Testa A, Giacomini D, Carrozza C, Maussier ML, Valenza V, D'Errico GF.
    Q J Nucl Med; 1996 Jun 14; 40(2):182-7. PubMed ID: 8909104
    [Abstract] [Full Text] [Related]

  • 13. Serum thyrotropin response to thyrotropin-releasing hormone and free thyroid hormone indices in patients with familiar thyroxine-binding globulin deficiency.
    Konno N.
    Endocrinol Jpn; 1976 Aug 14; 23(4):313-7. PubMed ID: 828576
    [Abstract] [Full Text] [Related]

  • 14. Serum thyrotropin response to thyrotropin-releasing hormone and free thyroid hormone indices in patients with familial thyroxine-binding globulin deficiency.
    Konno N.
    Endocrinol Jpn; 1977 Aug 14; 23(4):313-7. PubMed ID: 72658
    [Abstract] [Full Text] [Related]

  • 15. Correlation between thyroxine, triiodothyronine and thyrotropin in geriatric patients with goitre.
    Varl B, Pavlin K.
    Acta Med Austriaca; 1990 Aug 14; 17 Suppl 1():71-3. PubMed ID: 2389637
    [Abstract] [Full Text] [Related]

  • 16. Assessment of the clinically significant TSH response to TRH in patients with nodular goitre.
    Kirkegaard C, Bregengård C.
    Horm Metab Res; 1988 Jun 14; 20(6):357-9. PubMed ID: 3138170
    [Abstract] [Full Text] [Related]

  • 17. [Can the thyrotropin (TSH) suppressive dose of L-thyroxine (T4) be individually predicted in athyroid patients?].
    Kainz H, Weissel M.
    Acta Med Austriaca; 1990 Jun 14; 17(2-3):50-4. PubMed ID: 2120901
    [Abstract] [Full Text] [Related]

  • 18. [Therapy of euthyroid iron deficiency goiter. Effectiveness of a combination of L-thyroxine and 150 micrograms iodine in comparison with mono-L-thyroxine].
    Grussendorf M.
    Med Klin (Munich); 1996 Aug 15; 91(8):489-93. PubMed ID: 8965746
    [Abstract] [Full Text] [Related]

  • 19. [Changes in serum levels of T4, T3 and TSH in TRH stimulation test among normal adults].
    Liu GZ, Song YH, Pan WR, Li GF, Liu CS, Bai Y, Zhang ZJ, Li ZH.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Oct 15; 5(5):290-4. PubMed ID: 6234078
    [No Abstract] [Full Text] [Related]

  • 20. [TRH-TSH regulation in the aged and in patients with senile dementia].
    Stähelin HB, Staub JJ, Hew-Winzeler AM, Seiler WO, Girard J.
    Schweiz Med Wochenschr; 1982 Dec 04; 112(49):1784-6. PubMed ID: 6817414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.